A Canadian Breakthrough in Multi-Cancer Early Detection (MCED) has arrived.
Canada is known for leading the world in medical science. La Vie is proud to offer Canada’s latest example of this in a multi-cancer screening test. Using advanced technology, the MCED test identifies early cancer signals at a crucial stage: when they are most treatable.
Understanding Multi-Cancer Early Detection (MCED)
Most cancer screening tests check for one type of cancer at a time. A mammogram checks for breast cancer. A colonoscopy checks the colon. These tests are important but they only cover a small number of the many cancers that exist. Most of the aggressive cancers (such as pancreatic, liver or ovarian cancers) are not part of regular screening guidelines and so are not tested (or discovered) until symptoms develop in the later stages. By then, they can be harder to treat.
Our Multi-Cancer Early Detection (MCED) panel, the CanScanPro™ helps close the gap between finding cancer and successfully treating cancer. Using just one simple blood draw, this test looks for tiny signs of cancer that may be present anywhere in the body. It checks for signals linked to 13 to 21 or more organ systems.
The Canadian Difference
The CanScanPro™ test was developed using Canadian research and world-class science. It reflects something Canada does again and again: turn bold ideas into real-world medical
breakthroughs.
Canadian scientists have long been leaders in health innovation, from the discovery of insulin to groundbreaking cancer research today. MCED is the newest example of that same spirit. Canadian Minds, Canadian labs, and Canadian innovation are once again helping shape the future of medicine. And now, that future is available at La Vie Health.
How MCED Works
The test looks at tiny pieces of genetic material, called cell-free DNA (cfDNA) that cells release into the blood. Using advanced computer tools and lab technology, the test studies patterns in this DNA. These patterns can point to early cancer activity—often before any symptoms appear. If a signal is found, the test can also help predict which organ it may be coming from. This helps your doctor decide what to check next.
Key Benefits
- Unprecedented Multi-Organ Coverage: Checks for signals linked to many types of cancers at once from 13 to 21+ organ systems. Including cancer with no routine screening today.
- Points to the Source: If a signal is found, the test helps predict where in the body it may be coming from.
- Highly Accurate: Built with approximately 98% specificity, meaning very few false positives.
- Catches Problems Early: Early detection often means more treatment options and better outcomes.
- Simple and Easy: Just one quick blood draw at our La Vie Health clinic.
What The CanScanPro™ Test Can Check For
Our comprehensive MCED panel looks for signals connected to many organ systems, including;
- Digestive System: Pancreas, Liver, Stomach, Esophagus, Gallbladder, Colon & Rectum
- Reproductive System: Ovaries, Uterus/Endometrium, Cervix, Breast, Prostate
- Respiratory & Thoracic: Lungs, Bronchus, Head & Neck region
- Hematologic Systems: Blood-related cancers, such as lymphoma
The Patient Experience at La Vie Health
Step 1: A Simple Blood Draw
Visit our clinic for a quick, comfortable blood draw. A trained member of our team will take care of you.
Step 2: Lab Analysis
Your sample is studied using advanced lab technology and computer analysis. This process looks at billions of data points in your DNA for cancer-related signals.
Step 3: Your Results, Explained by a Doctor
Within 2 to 3 weeks, your results are ready. You will meet with a La Vie Health doctor for a 25-minute conversation. They will explain your results clearly and walk you through next steps.
Step 4: Support If You Need It
If a signal is found, your doctor will act quickly. This is a screening test, not a diagnostic test, so they will arrange the right follow-up texts. This could include an MRI, CT, or PET Scan, based on the signal points.
Frequently Asked Questions
- Does the CanScanPro™ test replace my regular mammogram, Pap test, or colonoscopy?
No. MCED screening is designed to complement, not replace, standard guideline-recommended
screenings. Standard screenings remain the gold standard for specific organs like the breasts
and colon. MCED adds a crucial layer of security by screening for cancers that standard routine
tests miss.- Is an MCED test considered a definitive diagnosis?
No. This test is a highly sophisticated risk screening tool. A positive signal indicates that
cancer-associated biomarkers were detected in the blood and pinpoints the likely tissue of
origin. Your physician will order targeted diagnostic tests (like diagnostic imaging or biopsies) to
confirm or rule out the presence of disease.- What does a “No Signal Detected” result mean?
A “No Signal Detected” result indicates that no actionable cancer signatures were found in your
blood sample at the time of testing. While highly reassuring, it does not guarantee that cancer
will never develop, which is why maintaining routine check-ups and standard screenings
remains important.- Who is the ideal candidate for MCED screening?
MCED screening is particularly recommended for proactive adults aged 40 and older,
individuals with a personal or family history of cancer, individuals exposed to environmental risk
factors, or anyone seeking to incorporate cutting-edge preventive testing into their executive
assessment.